Neuberger Berman Group LLC Raises Position in Fresenius Medical Care Corporation (FMS)

Neuberger Berman Group LLC boosted its position in shares of Fresenius Medical Care Corporation (NYSE:FMS) by 3.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,711 shares of the company’s stock after buying an additional 1,537 shares during the period. Neuberger Berman Group LLC’s holdings in Fresenius Medical Care Corporation were worth $2,094,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC raised its stake in Fresenius Medical Care Corporation by 12.7% in the first quarter. Quadrant Capital Group LLC now owns 3,736 shares of the company’s stock worth $149,000 after buying an additional 420 shares in the last quarter. Greenleaf Trust purchased a new stake in Fresenius Medical Care Corporation during the first quarter worth about $205,000. Trexquant Investment LP purchased a new stake in Fresenius Medical Care Corporation during the fourth quarter worth about $215,000. State Street Corp raised its stake in Fresenius Medical Care Corporation by 1.2% in the fourth quarter. State Street Corp now owns 6,694 shares of the company’s stock worth $283,000 after buying an additional 79 shares in the last quarter. Finally, Wrapmanager Inc. raised its stake in Fresenius Medical Care Corporation by 3.5% in the first quarter. Wrapmanager Inc. now owns 7,222 shares of the company’s stock worth $304,000 after buying an additional 244 shares in the last quarter. Institutional investors and hedge funds own 2.83% of the company’s stock.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Shares of Fresenius Medical Care Corporation (NYSE FMS) traded down 0.44% on Tuesday, reaching $49.24. 15,332 shares of the company were exchanged. The stock has a 50 day moving average price of $47.10 and a 200-day moving average price of $43.00. The stock has a market capitalization of $30.16 billion, a P/E ratio of 21.47 and a beta of 0.51. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22.

Fresenius Medical Care Corporation (NYSE:FMS) last released its earnings results on Wednesday, May 3rd. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.09. Fresenius Medical Care Corporation had a net margin of 7.24% and a return on equity of 11.79%. The business had revenue of $4.55 billion during the quarter, compared to analysts’ expectations of $4.69 billion. During the same period last year, the business earned $0.75 earnings per share. On average, equities analysts expect that Fresenius Medical Care Corporation will post $2.25 EPS for the current fiscal year.

The company also recently announced an annual dividend, which was paid on Friday, May 26th. Investors of record on Monday, May 15th were paid a $0.5137 dividend. The ex-dividend date of this dividend was Thursday, May 11th. This represents a dividend yield of 1.17%. Fresenius Medical Care Corporation’s dividend payout ratio is presently 16.97%.

ILLEGAL ACTIVITY WARNING: “Neuberger Berman Group LLC Raises Position in Fresenius Medical Care Corporation (FMS)” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/2655201/neuberger-berman-group-llc-raises-position-in-fresenius-medical-care-corporation-fms.html.

FMS has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $49.00 price target on the stock in a report on Tuesday, April 25th. Sanford C. Bernstein restated a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Sunday, March 12th. DZ Bank AG reaffirmed a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Tuesday, March 7th. Societe Generale downgraded shares of Fresenius Medical Care Corporation from a “buy” rating to a “hold” rating in a research report on Friday, February 24th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $44.00 price objective on shares of Fresenius Medical Care Corporation in a research report on Tuesday, May 30th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $47.00.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “FMS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care Corporation (NYSE:FMS).

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.